Neuro-Oncology Reviews

Volume 27 Number 34
10 December 2025

Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 34, 10 December

Jiang T, Nam DH, Ram Z, Poo WS, Wang J, Boldbaatar D, Mao Y, Ma W, Mao Q, You Y, Jiang C, Yang X, Tergaonkar V, Zhang W, Wang Z, Kang C, Qiu X, Li S, Chen L, Li X, Liu Z, Bai H, Yao Y, Li S, Wu A, Mou Y, Sai K, Li G, Wei X, Liu X, Zhang Z, Dai Y, Lv S, Wang L, Lin Z, Dong J, Xu G, Ma X, Yu R, Kang D, Liu Y, Li G, Zhang S, Qu Y, Wang Y, Zhang C, Chen B, You G, Wang Y, Wang Y, Bao Z, Fan X, Liu X, Zhao Z, Li Y, Wang Z, Li G, Fang S, Liu Y, Shan X, Liu Y, Chai R, Hu H, Chen J, Yan W, Cai J, Wang Y; Chinese Glioma Cooperative Group (CGCG), Society for Neuro-Oncology of China (SNOChina), Chinese Brain Cancer Association (CBCA), Chinese Glioma Genome Atlas (CGGA), Asian Glioma Genome Atlas (AGGA) network.
Updated Clinical practice guidelines for the management of adult diffuse gliomas.
Cancer Lett. 2025 Dec 1:218185. doi: 10.1016/j.canlet.2025.218185. PMID: 41338443. Guidelines˰ ˍ

Zheng B, Han Y, Zhang H.
Role of matrix metalloproteinases in the invasion of glioblastoma and drug interventions (Review).
Int J Mol Med. 2025 Dec 1;57(2):33. doi: 10.3892/ijmm.2025.5704. PMID: 41347826. Review. ˍ

Zamani H, Saeb M, Monadi S, Alizade-Harakiyan M, Akhavan A, Khodaei A, Molazadeh M, Farajollahi A.
Comparative effectiveness of advanced radiotherapy techniques for brain cancers: A systematic review with an emphasis on dosimetric variability.
Phys Med. 2025 Dec 3;140:105682. doi: 10.1016/j.ejmp.2025.105682. PMID: 41343911. Review. ˍ

Harary PM, Hori YS, Annagiri S, Abe K, Tatekoshi Y, Hosoda R, Saga Y, Park DJ, Kuno A, Chang SD.
Enhancing radiation sensitivity in malignant brain tumors with chloroquine: a systematic review.
J Neurooncol. 2025 Dec 5;176(1):106. doi: 10.1007/s11060-025-05362-w. PMID: 41348255. Review˰ ˍ

Nabavizadeh A, Narsinh K, Kaufmann TJ, Liu H, Pouliopoulos AN, Prada F, Agarwal V, Ellingson BM, Sanvito F, Everson RG, Meng Y, Gandhi D, Chang SM, Wen PY, Ahluwalia MS, Sul N, Hadley L, Leblang S, Shah BR, Arvanitis CD, Burns TC, Moosa S, Woodworth GF.
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical Applications.
AJNR Am J Neuroradiol. 2025 Dec 5:ajnr.A9126. doi: 10.3174/ajnr.A9126. PMID: 41360502. Review˰ ˍ

Wei Y, Shi Y, Wang H, Shang Y, Yu B, Zhang Y.
Glioblastoma insights: Focus on crosstalk with the suppressive tumor microenvironment and advanced therapeutic strategies.
Medicine (Baltimore). 2025 Dec 5;104(49):e46285. doi: 10.1097/MD.0000000000046285. PMID: 41366964. Review. ˍ

Kaina B, Christmann M.
Senotherapeutics in Malignant Brain Cancer Therapy.
Curr Oncol Rep. 2025 Dec 6. doi: 10.1007/s11912-025-01733-8. PMID: 41350483. Review. ˍ

Hsueh B, Steuart SJ, Odukoya AO, Prager BC, Kim YJ, Hill CM, Choi BD, Dunn GP.
Immunotherapy and targeted therapy for high grade gliomas: current and future directions.
J Neurooncol. 2025 Dec 9;176(1):112. doi: 10.1007/s11060-025-05315-3. PMID: 41366148. Review˰ ˍ

Mizutani Y, Hori YS, Harary PM, Annagiri S, Jain R, Liu J, Izhar M, Reesh DA, Lam FC, Emrich SC, Ustrzynski L, Tayag A, Park DJ, Chang SD.
Radiosurgical management of pathology-proven low-grade glioma: a systematic review across the pre- and post-molecular classification era.
J Neurosurg Sci. 2025 Dec 9. doi: 10.23736/S0390-5616.25.06656-1. PMID: 41364089. Review. ˍ

Wo XW, Zhu HF, Xu N.
Dynamic susceptibility contrast perfusion in differentiation between recurrence and pseudoprogression in glioblastoma: a systematic review and meta-analysis.
Quant Imaging Med Surg. 2025 Nov 14;15(12):12336-12345. doi: 10.21037/qims-2025-245. PMID: 41367751. Review; Meta-analysis. ˍ

Trejo-Solís C, Rojas-Tomé IS, Jung-Cook H, Palomares-Alonso F.
Melatonin combined with antineoplastic drugs or natural products for cancer treatment: An update.
Curr Res Pharmacol Drug Discov. 2025 Nov 17;9:100239. doi: 10.1016/j.crphar.2025.100239. PMID: 41341468. Review. ˍ